Discovery of a potent orally available pyrazolopyridone derivative as a novel selective bromodomain and extra-terminal domain (BET)-first bromodomain (BD1) inhibitor.
Hagihara S, Ishizawa K, Soga K, Honjo T, Takai S, Kawano Y, Kikuchi M, Nishidate A, Matsumoto F, Murase M, Hashimoto N, Sasaki C, Miyaguchi I, Okada O, Akashi T, Nakayama S, Ogasawara Y, Endo J.
Hagihara S, et al. Among authors: hashimoto n.
Bioorg Med Chem Lett. 2024 Jun 12;109:129849. doi: 10.1016/j.bmcl.2024.129849. Online ahead of print.
Bioorg Med Chem Lett. 2024.
PMID: 38876177